Abbott India MD Vivek Kamath resigns
His resignation would be effective from March 18, 2024
His resignation would be effective from March 18, 2024
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey
His most recent stint was with Danone India as its Managing Director
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
Leading USA based genetic testing brand officially enters the Indian market
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
Subscribe To Our Newsletter & Stay Updated